SEC Form 4 · accession 0001140361-18-028130
STRATA Skin Sciences, Inc. · SSKN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
David N Gill
Director
Period of report
Jun 8, 2018
Accepted (ET)
Jun 11, 2018 · 6:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001051514
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| STRATA Restricted Stock UnitsF1 | $2.07 | Jun 8, 2018 | A | 26,570 | A | Jun 8, 2019 | Jun 8, 2028 | Common Stock | 26,570 | 26,570 | D |
Explanation of responses
- F1Restricted Stock Options will vest 100%, in equal quarterly installments, over a 12 month period.